Sign in to continue:

Friday, January 30th, 2026

ValueMax Group Issues 40,000 New Shares from Warrant Exercise at S$0.36 Each – December 2025 Update

ValueMax Group Limited Announces Allotment and Issuance of Shares Following Warrant Exercise

ValueMax Group Limited Announces Allotment and Issuance of Shares Following Warrant Exercise

Key Points from the Announcement

  • Increase in Issued Share Capital: ValueMax Group Limited has increased its issued ordinary shares from 940,063,259 to 940,103,259. This is due to the allotment and issuance of 40,000 new ordinary shares following the exercise of warrants.
  • Warrant Exercise Details: The 40,000 new shares were issued at an exercise price of S\$0.36 per share, with the exercise taking place on 19 December 2025.
  • Listing of New Shares: These new shares will be listed and quoted on the Singapore Exchange Securities Trading Limited on 23 December 2025. The new shares will rank pari passu in all respects with the existing shares of the company.
  • Outstanding Warrants: After this exercise, there remain 7,702,050 outstanding warrants, each with an exercise price of S\$0.36. These warrants will expire at 5.00 p.m. on 14 September 2026.

Important Information for Shareholders

  • Share Dilution: The issuance of 40,000 new shares represents a minor dilution of existing shareholders’ stakes. However, the current increase is relatively small compared to the total issued shares.
  • Potential for Further Dilution: With 7,702,050 outstanding warrants still in circulation, there is the potential for further dilution if these warrants are exercised prior to their expiry in September 2026. This could increase the total share base and impact earnings per share and overall share value.
  • Warrant Exercise Price: The warrant exercise price is fixed at S\$0.36, which could act as a reference point for future share price movements, especially as the expiry date approaches or if there is significant warrant conversion activity.
  • Liquidity Impact: The listing and trading of the new shares may enhance liquidity for ValueMax shares, offering increased flexibility for investors.

Potential Share Price Impact

The announcement of new shares being issued and listed, albeit a small amount, typically signals active participation in the warrant program and could indicate investor confidence in the company’s future prospects. However, the potential for further share dilution due to the outstanding warrants may weigh on the stock if exercised in significant numbers, particularly as the expiry approaches. Investors should monitor the conversion rate of outstanding warrants closely as it could affect supply and demand dynamics for the company’s shares.

Conclusion

ValueMax Group Limited’s latest share issuance is part of a routine warrant exercise. While the immediate dilution is minimal, the large number of outstanding warrants may impact share value over the medium term. Shareholders and potential investors should keep a close eye on future warrant exercises and overall market activity related to these instruments.


Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult with a qualified financial advisor before making investment decisions.


View ValueMax W260914 Historical chart here



Memiontec Holdings Ltd Announces Renounceable Non-Underwritten Rights Cum Warrants Issue

Key Points: The Company will issue up to 440,514,000 rights shares at S\$0.009 per share. The rights shares will be issued on the basis of 2 rights shares for every 3 existing shares held....

AVJennings Pays Fully Franked Special Dividend and Updates Scheme Consideration – August 2025 Announcement1

AVJennings Pays Special Dividend and Adjusts Scheme Consideration: What Shareholders Need to Know Key Points for AVJennings Shareholders Special Dividend Paid: AVJennings Limited (ASX: AVJ) has paid a fully franked special dividend of \$0.167...

Quantum Healthcare Limited Updates on Going Concern Status Amid Loan Demands, New Funding, and Debt Conversion Plans (September 2025)

Quantum Healthcare Faces Critical Funding and Debt Restructuring: Major Changes to Going Concern Status Could Impact Share Price Quantum Healthcare Faces Critical Funding and Debt Restructuring: Major Changes to Going Concern Status Could Impact...